Aptose Biosciences Inc.
Aptose Biosciences Inc. (APTO) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
apto · stock forecast · 11 analysts (3M) · FMP · updated Feb 6, 2026
Analyst Rating & Consensus
Based on 11 Wall Street analysts in the past 3 months
Buy
11 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $1.71
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $1.62 | ↓ 5.00% |
1-day model range: $1.54–$1.7. Peak: $1.7 (-5.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · APTO · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-03-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-02-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-01-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-12-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-12-03 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-08-11 | RBC Capital | Maintains | Outperform→Outperform |
| 2023-08-11 | Piper Sandler | Maintains | Overweight→Overweight |
| 2023-08-11 | Oppenheimer | Maintains | Outperform→Outperform |
| 2023-08-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Aptose Biosciences Inc. (APTO) stock. Of the recent 34 rating actions, 2 were upgrades and 0 were downgrades. 11 analysts currently cover APTO.
Analyst Recommendation Trends
APTO analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
↓ 100.0% YoY
Revenue Next Year
$1M
EPS This Year
$-42.84
EPS Next Year
$-9.20
↓ 78.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast APTO EPS of $-42.84 for the current fiscal year, based on estimates from 1 analysts. The APTO revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The APTO stock forecast is supported by two independent data sources: analyst consensus ratings from 11 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus APTO price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
The APTO short-term stock prediction for tomorrow is $1.62 (-5.00%).
Aptose Biosciences Inc. trades on NASDAQ under the ticker APTO. The APTO stock outlook for 2027 is broadly positive, supported by a Buy consensus among 91% of covering analysts.
Frequently asked questions
APTO forecast · 8 questionsAccording to 11 Wall Street analysts, the average 12-month APTO price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $1.71.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.